Proprio

Industry
Medical Technology
Founded Year
2016
Headquarters
Seattle, Washington, USA
Employee Count
50

Key People

  • Gabriel Jones - CEO
  • Samuel Browd, MD, PhD - Chief Medical Officer
  • James Youngquist - CTO

Assessment

Team
Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with over a decade in their respective fields.

Proprio's leadership includes individuals with significant experience in medical technology and business, enhancing the company's strategic direction and operational execution.

Clinical Need
Aspect: Very Strong
Summary: Proprio addresses a critical need for advanced surgical navigation and imaging solutions.

With the increasing complexity of surgical procedures, there is a substantial demand for technologies that improve accuracy and outcomes, which Proprio's products aim to fulfill.

Competition
Aspect: Somewhat crowded
Summary: The surgical navigation market has several established players, but opportunities exist for innovation.

The market includes companies like Medtronic and Stryker; however, Proprio's integration of light field technology and AI provides a competitive edge.

Technical Challenge
Aspect: Complex
Summary: Developing and integrating advanced imaging and AI technologies into surgical workflows is complex.

Creating real-time 3D visualization systems that seamlessly integrate into existing surgical practices requires overcoming substantial technical hurdles.

Patent
Aspect: Strong
Summary: Proprio holds a robust patent portfolio protecting its core technologies.

A strong intellectual property position safeguards Proprio's technological advancements and supports its market position.

Financing
Aspect: Well-funded
Summary: Proprio has secured significant funding, including a $43 million Series B round in July 2023.

The Series B funding round, led by prominent investors, provides the necessary capital for scaling operations and market entry.

Regulatory
Aspect: Running FIH
Summary: Proprio is conducting first-in-human trials to validate its technology.

Successful first-in-human trials are critical for demonstrating safety and efficacy, paving the way for regulatory submissions.

Opportunity Rollup

Odds of Success
3.6
Peak Market Share
4.6
Segment CAGR
10.09%
Market Segment
Surgical Navigation Systems
Market Sub Segment
Orthopedic and Neurosurgical Navigation
Year Post Launch Market Penetration (%)
1 0.23
2 0.69
3 1.61
4 3.22
5 4.60

Key Takeaway

Proprio's innovative approach to surgical navigation positions it well in a growing market, though challenges in competition and technical complexity remain.